Impact of Chemotherapy Educational Videos for Patients with Acute Myeloid Leukemia

被引:0
|
作者
Gabbard, Taylor [1 ,2 ]
Perissinotti, Anthony J. [1 ,2 ]
Benitez, Lydia L. [1 ,2 ]
Fraga, Martina [1 ,2 ]
Pettit, Kristen M. [3 ]
Bixby, Dale L. [3 ]
Burke, Patrick W. [3 ]
Marini, Bernard L. [1 ,2 ]
机构
[1] Michigan Med, Dept Clin Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Med Sch, Ann Arbor, MI USA
关键词
AML; Patient education; Video;
D O I
10.1007/s13187-024-02473-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patient education in acute myeloid leukemia (AML) has become increasingly complex with the introduction of new treatments and chemotherapy regimens. Video education presents an opportunity to supplement traditional patient education and address some of the gaps associated with standard methods. This single-center study sought to assess the potential impact of supplemental video education on patients receiving induction chemotherapy for AML. Participants were consented to be randomized to receive their education with or without a supplemental video designed for their treatment regimen. We then provided a survey to each participant to assess knowledge retention, anxiety, and overall satisfaction with their care. Patients that received video education were found to have significantly improved knowledge retention compared to those that did not. There were no differences detected in anxiety or patient satisfaction. Video education appears to be an effective supplemental method for patient education in AML. Limitations include the single-center nature of the study at an urban academic medical center with a relatively well-educated, primarily Caucasian, younger population. Future research is warranted to assess the video in a diverse set of languages and to explore its broader benefits.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [21] Impact of 9q deletions on the classification of patients with acute myeloid leukemia
    Bettina Balk
    Torsten Haferlach
    Manja Meggendorfer
    Wolfgang Kern
    Claudia Haferlach
    Anna Stengel
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2871 - 2874
  • [22] Cardiovascular Disease and Diabetes Mellitus Impact Outcomes of Patients With Acute Myeloid Leukemia
    Sanchez-Petitto, Gabriela
    Goloubeva, Olga G.
    Masur, Jack
    Childress, James
    Iqbal, Tahreem
    An, Max
    Muhammad, Safwan
    Lawson, Justin
    Barr, Brian
    Emadi, Ashkan
    Law, Jennie
    Duong, Vu H.
    Baer, Maria R.
    Niyongere, Sandrine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S242 - S243
  • [23] Early gene expression of acute myeloid leukemia in response to chemotherapy
    Anensen, Nina
    Oyan, Anne M.
    Huseby, Sjur
    Kalland, Korl-Henning
    Bruserud, Oystein
    Gjertsen, Bjorn T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (05) : 741 - 751
  • [24] Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia
    Falini, Brunangelo
    Martelli, Maria Paola
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2015, 28 (2-3) : 90 - 97
  • [25] Impact of Weekend Admissions on Quality of Care and Outcomes in Patients With Acute Myeloid Leukemia
    Bejanyan, Nelli
    Fu, Alex Z.
    Lazaryan, Aleksandr
    Fu, Rao
    Kalaycio, Matt
    Advani, Anjali
    Sobecks, Ronald
    Copelan, Edward
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    CANCER, 2010, 116 (15) : 3614 - 3620
  • [26] Are adjuncts to induction chemotherapy worthwhile in the treatment of acute myeloid leukemia?
    Ravandi, Farhad
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (3-4) : 241 - 246
  • [27] Impact of 9q deletions on the classification of patients with acute myeloid leukemia
    Balk, Bettina
    Haferlach, Torsten
    Meggendorfer, Manja
    Kern, Wolfgang
    Haferlach, Claudia
    Stengel, Anna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (11) : 2871 - 2874
  • [28] Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapy
    Richard-Carpentier, Guillaume
    DiNardo, Courtney D.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [29] ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemia
    Hartsock, Bobbi
    Lim, Matthew J.
    Roth, Christine Garcia
    Raptis, Nepheli
    Weber, David
    Sehgal, Alison
    Boyiadzis, Michael
    Raptis, Anastasios
    Hou, Jing-Zhou
    Im, Annie
    Dorritie, Kathleen
    Marks, Stanley
    Agha, Mounzer
    Lim, Seah H.
    LEUKEMIA RESEARCH, 2016, 48 : 16 - 19
  • [30] Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
    Burnett, Alan K.
    Russell, Nigel H.
    Hills, Robert K.
    Kell, Jonathan
    Freeman, Sylvie
    Kjeldsen, Lars
    Hunter, Ann E.
    Yin, John
    Craddock, Charles F.
    Dufva, Inge Hoegh
    Wheatley, Keith
    Milligan, Donald
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3924 - 3931